Skip Navigation

European Journal of Heart Failure 2002 4(3):255-262; doi:10.1016/S1388-9842(01)00232-X
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by van den Berg, M. P.
Right arrow Articles by van Veldhuisen, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van den Berg, M. P.
Right arrow Articles by van Veldhuisen, D. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2002 European Society of Cardiology

Longstanding atrial fibrillation causes depletion of atrial natriuretic peptide in patients with advanced congestive heart failure

Maarten P. van den Berga,*, Geert Tjeerdsmaa, Pieter Jan de Kama, Frans Boomsmab, Harry J.G.M. Crijnsa and Dirk J. van Veldhuisena

a Department of Cardiology, Thorax Center University Hospital Groningen, P.O. Box 30.001, 9700 RB Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands
b COEUR/Department of Internal Medicine University Hospital Dijkzigt, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands

* Corresponding author. Tel.: +31-50-361-2355; fax: +31-50-361-4391. E-mail address: m.p.van.den.berg{at}thorax.azg.nl


   Abstract

Background: Congestive heart failure (CHF) is characterized by neurohormonal activation, including increased plasma concentrations of atrial natriuretic peptide (ANP) and N-terminal ANP (N-ANP). Onset of atrial fibrillation (AF) further increases these peptides, but it may be hypothesized that concentrations decrease during longstanding AF due to inherent atrial degeneration.

Aim: We sought to investigate the relation between neurohormonal activation in patients with CHF and the duration of concomitant AF.

Methods: The study group comprised 60 patients (age 70±8 years) with advanced CHF due to left ventricular systolic dysfunction (left ventricular ejection fraction (LVEF) <0.35) and chronic AF (duration 21 (1–340) months). Plasma neurohormone concentrations were measured, and multiple regression analysis was performed to identify their clinical predictors.

Results: Median plasma neurohormone concentrations were: ANP 113 pmol/l, N-ANP 1187 pmol/l, norepinephrine 496 pg/ml, renin 127 µunits/l, aldosterone 128 pg/ml and endothelin 8.1 pg/ml. Norepinephrine, renin, aldosterone and endothelin were not significantly related to the duration of AF. In contrast, ANP decreased along with the duration of AF (P=0.03), while the same trend was observed for N-ANP (P=0.10). However, for these peptides a first order interaction with LVEF was present, which was not observed in the other neurohormones. In patients with LVEF >0.25 ANP and N-ANP increased along with the duration of AF, whereas in patients with LVEF≤0.25 an inverse relation between ANP (P=0.02) and N-ANP (P=0.04) and the duration of AF was present, longer-standing AF being associated with lower concentrations.

Conclusion: In patients with advanced CHF with low LVEF plasma ANP and N-ANP concentrations decrease during longstanding AF. This finding agrees with the concept that longstanding AF leads to impaired ability of the atria to produce these neurohormones due to inherent degenerative changes.

Key Words: Congestive heart failure • Atrial fibrillation • Atrial natriuretic peptide

Received February 28, 2001; Revised August 31, 2001; Accepted October 23, 2001


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
G. Casaclang-Verzosa, B. J. Gersh, and T. S.M. Tsang
Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation.
J. Am. Coll. Cardiol., January 1, 2008; 51(1): 1 - 11.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
C. A. Dezsi, A. Szucs, G. Szucs, A. Roka, O. Kiss, D. Becker, and B. Merkely
Short-term effect of rate control on plasma endothelin levels of patients with tachyarrhythmias.
Experimental Biology and Medicine, June 1, 2006; 231(6): 852 - 856.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. A. Laukkanen, S. Kurl, M. Ala-Kopsala, O. Vuolteenaho, H. Ruskoaho, K. Nyyssonen, and J. T. Salonen
Plasma N-terminal fragments of natriuretic propeptides predict the risk of cardiovascular events and mortality in middle-aged men
Eur. Heart J., May 2, 2006; 27(10): 1230 - 1237.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
J. G.F. Cleland and K. Goode
Natriuretic peptides for heart failure. Fashionable? Useful? Necessary?
Eur J Heart Fail, March 15, 2004; 6(3): 253 - 255.
[Full Text] [PDF]


Home page
NEJMHome page
T. J. Wang, M. G. Larson, D. Levy, E. J. Benjamin, E. P. Leip, T. Omland, P. A. Wolf, and R. S. Vasan
Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death
N. Engl. J. Med., February 12, 2004; 350(7): 655 - 663.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
M. P. van den Berg, I. C. van Gelder, and D. J. van Veldhuisen
Depletion of atrial natriuretic peptide during longstanding atrial fibrillation
Europace, January 1, 2004; 6(5): 433 - 437.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. Wozakowska-Kaplon and G. Opolski
Concomitant recovery of atrial mechanical and endocrine function after cardioversion in patients with persistent atrial fibrillation
J. Am. Coll. Cardiol., May 21, 2003; 41(10): 1716 - 1720.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.